28.10.2016 • NewsDede WillamsSABICExxonMobil

SABIC JV Starts Rubber Production

Saudi Arabian chemicals giant SABIC has started commercial production of polybutadiene industrial rubber as part of part of its Al-Jubail Petrochemical Company (KEMYA) joint venture with Exxon Mobil subsidiary Exxon Chemical Arabia. The Saudi company has also begun trial operations at the ethylene propylene diene monomer unit of the KEMYA complex.

The rubber plant, built at a cost $3.4 billion, will produce more than 400,000 t/y of product, including rubber, thermoplastic polymers and carbon black for domestic markets and for export to Asia. When announcing the project in 2011, SABIC said it had signed two deals with Continental Carbon for a technology license and marketing of the carbon black produced at the facility.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.